Latest news
May 24, 2007
Salvacyl®/ Maopar® 3-month obtains european mutual recognition to treat sexual deviations
April 19, 2007
Clinical update – Debio 025 cyclophilin inhibitor for the treatment of HCV – A unique viral kinetics
March 12, 2007
Preclinical update – Debio-0512 therapeutic vaccine for the treatment of chronic and acute inflammatory conditions – Proof of concept in…
January 30, 2007
Debiopharm signs R&D and Commercialisation Agreement with Kirin for the development of Debio-0719 in Oncology
October 31, 2006
Debiopharm presents new data confirming anti-HCV activity of cyclophilin inhibitor for Debio-025